Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010

Human and Experimental Toxicology

Volumn 31, Issue 10, 2012, Pages 1012-1021

  Goldman, G S ^a   Miller, N Z ^b  

^a Computer Scientist ^*  (United States)

^b Thinktwice Vaccine Institute   (United States)

Author keywords

childhood vaccines; drug toxicology; epidemiology; human toxicology; immunization; infant mortality; SIDS; vaccine; VAERS

Indexed keywords

VACCINE;

AGE; ARTICLE; DOSE RESPONSE; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT MORTALITY; INFANT, NEWBORN; LINEAR MODELS; MALE; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VACCINATION; VACCINES;

EID: 84867549169     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112440111     Document Type: Article

References (27)

1. Guess HA. Combination vaccines: issues in evaluation of effectiveness and safety. Epidemiol Rev. 1999 ; 21 (1). 93
2. Miller NZ, Goldman GS. Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?. Hum Exp Toxicol. 2011 ; 30 (9). 1420-1428
3. Delong G. A positive association found between autism prevalence and childhood vaccination uptake across the U.S. population. J Toxicol Environ Health A. 2011 ; 74 (14). 903-916
4. Castranova V, Graham J, Hearl F, Herrick R, Hertzberg R, Hoover MD, et al Mixed exposures research agenda: a report by the NORA Mixed Exposures Team. Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH); DHHS (NIOSH) 2004 ; 2005: 106:vi.
5. Oestergaard MZ, Inoue M, Yoshida S, Mahanani WR, Gore FM, Cousens S, et al. Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities. PLoS Med. 2011 ; 8 (8). e1001080
6. Gran B, Bielekova B, McFarland HF, Martin R. Development of multiple sclerosis after hepatitis B vaccination. Neurology. 2000 ; 54 (suppl 3). A164
7. Hernán MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2004 ; 63: 838-842
8. Terney D, Beniczky S, Barsi P, Kondákor I, Perényi J, Faludi B, et al. Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Chin Med J. 2006 ; 119 (1). 77-79
9. Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology. 2009 ; 72 (10). 873-880
10. Ness JM, Bale JF. Hepatitis vaccines and pediatric multiple sclerosis. Does timing or type matter?. Neurology. 2009 ; 72 (10). 870-871
11. Sinsawaiwong S, Thampanitchawong P. GuillainBarré syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai. 2000 ; 83 (9). 1124-1126
12. Konstantinou D, Paschalis C, Maraziotis T, Dimopoulos P, Bassaris H, Skoutelis A. Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient. Clin Inf Dis. 2001 ; 33: 1772-1773
13. Vaccine safety committee proceedings. Washington, DC: National Academy of Sciences ; 1992: 40-41.
14. Kessler DA. Natanblut S, Kennedy D, Lazar E, Rheinstein P, et al. Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993 ; 269 (21). 2765
15. Rosenthal S, Chen RT. Reporting sensitivities of two passive surveillance systems for adverse events. Am J Public Health. 1995 ; 85: 1706-1709
16. Ottaviani G, Lavezzi AM, Matturri L. Sudden infant death syndrome (SIDS) shortly after hexavalent vaccination: another pathology in suspected SIDS?. Virchows Arch. 2006 ; 448 (1). 100-104
17. Kuhnert R, Hecker H, Poethko-Müller C, Schlaud M, Vennemann M, Whitaker HJ, et al. A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med. 2011 ; 30 (6). 666-677
18. Zinka B, Rauch E, Buettner A, Rueff F, Penning R. Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine. 2006 ; 24 ((31-32)). 5779-5780
19. Geier DA, Geier MR. A review of the Vaccine Adverse Event Reporting System database. Expert Opin Pharmacother. 2004 ; 5 (3). 691-698
20. Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004 ; 23 (4). 287-294
21. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ. 2003 ; 52 (1). 1-24
22. Dettman G, Kalokerinos A, Dettman I Vitamin C, Nature's Miraculous Healing Missile!. Melbourne: Frederick Todd ; 1993: 1-422.
23. Prandota J. Possible pathomechanisms of sudden infant death syndrome: key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants. Am J Ther. 2004 ; 11 (6). 517-546
24. Poling JS, Frye RE, Shoffner J, Zimmerman AW. Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol. 2006 ; 21 (2). 170-172
25. BraunM. Vaccine Adverse Event Reporting System (VAERS): usefulness and limitations. Johns Hopkins Bloomburg School of Public Health, http://www.vaccinesafety.edu/VAERS.htm(2006, accessed 9 November 2011).
26. Mage DT, Donner EM. The fifty percent male excess of infant respiratory mortality. Acta Paediatr. 2004 ; 93 (9). 1210-1215
27. Moon R, Fu L. Sudden infant death syndrome. Pediatr Rev. 2007 ; 28: 209-214